Spots Global Cancer Trial Database for rezvilutamide
Every month we try and update this database with for rezvilutamide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | NCT05753566 | Prostate Cancer Biochemical Rec... | Rezvilutamide Androgen depriv... SRT | 40 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer | NCT06134271 | Metastatic Horm... | Rezvilutamide Rezvilutamide p... Continue previo... | 18 Years - | First Hospital of China Medical University | |
| Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC | NCT05956639 | Metastatic Horm... | 6-month course ... Long-term cours... | 18 Years - | The First Affiliated Hospital with Nanjing Medical University | |
| Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer | NCT05406999 | Neoadjuvant The... High Risk Prost... Locally Advance... Intense Endocri... | ADT Abiraterone Ace... Prednisolone ta... Enzalutamide Apalutamide Darotamide Rezvilutamide PARP inhibitor Robot-assisted ... | 18 Years - 80 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | NCT06305832 | Prostate Cancer Biochemical Rec... | Rezvilutamide Androgen depriv... SRT | 40 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC | NCT05956639 | Metastatic Horm... | 6-month course ... Long-term cours... | 18 Years - | The First Affiliated Hospital with Nanjing Medical University | |
| Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma | NCT06348264 | Salivary Gland ... | Rezvilutamide Leuprolide Acet... | 18 Years - | Peking University First Hospital | |
| Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) | NCT06387056 | Locally Advance... Oligometastatic... | Rezvilutamide Goserelin Micro... Docetaxel Pamiparib Cisplatin Tislelizumab | 18 Years - | The First Affiliated Hospital of Xiamen University | |
| Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC | NCT05983783 | Metastatic Pros... Hormone Sensiti... Chemotherapy Ef... | Docetaxel Rezvilutamide | 40 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
